Table: Solasia Pharma -2023 group forecast(IFRS)
Dec 28 (Reuters) -
Solasia Pharma K. K.
CONSOLIDATED EARNINGS ESTIMATES
(in billions of yen unless specified)
Full Year to Full Year to
Dec 31, 2023 Dec 31, 2023
LATEST PREVIOUS
FORECAST FORECAST
Sales 620 mln
Operating loss 1.15
PreTax loss 1.15
Net loss 1.15
EPS Basic loss 6.62 yen
NOTE - Solasia Pharma K. K..(Figures are reported based on international accounting rules (IFRS).)
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4597.T